Empowerment Provided by Health Education and its Impact on Self-care:
Report of a Pharmaceutical Intervention

Alan   Maicon   de Oliveira; Barbara   Falaschi   Romeiro; João Paulo   Vilela   Rodrigues; Fabiana   Rossi   Varallo; Leonardo   Regis   Leira Pereira

doi:10.2174/1574885518666230606105152

Abstract

Aims: Older people, due to the development of multiple morbidities and in a situation of polypharmacy, become fragile in addition to their own physical and organic aging. For different reasons regarding the treatment, the health care provided, or the physical and mental condition of older people, problems of adherence to pharmacotherapy are present. Pharmaceutical care is an important practice to ensure rational pharmacotherapy for this population. The present study aims to describe the report of pharmacotherapeutic follow-up of a hospitalized older individual with multimorbidity and use of polypharmacy and to highlight an intervention aimed at adherence to pharmacotherapy.

Case presentation: This is the planning of a strategy, aimed at promoting health education, which was carried out during the hospital stay of an older person who was included in the institution's pharmaceutical care services. In addition, at hospital discharge, in order to ensure greater benefits, a bag was made for the correct storage of medicines and a descriptive didactic list on how to use them. In this way, improvements were achieved in the transition of care for this patient.

Conclusion: The importance of developing techniques that promote adherence to pharmacotherapy, especially for fragile populations, such as older people with multiple diseases, and using polypharmacy is suggested. Individualized educational interventions are instructive measures that can contribute to people's autonomy in their self-care.

« Previous Next »

Graphical Abstract

[1]
World Health Organization. Decade of healthy ageing: Baseline
                    report. Geneva: WHO 2020.

[2]
World Health Organization. Medication safety in polypharmacy:
                    Technical report. Geneva: WHO 2019.

[3]
Yach D, Hawkes C, Gould CL, Hofman KJ. The global burden of chronic diseases: Overcoming impediments to prevention and control. JAMA  2004; 291(21): 2616-22.
 [http://dx.doi.org/10.1001/jama.291.21.2616] [PMID: 15173153]

[4]
Mills KT, Bundy JD, Kelly TN, et al. Global disparities of hypertension prevalence and control. Circulation  2016; 134(6): 441-50.
 [http://dx.doi.org/10.1161/CIRCULATIONAHA.115.018912] [PMID: 27502908]

[5]
Cipolle RJ, Strand LM, Morley PC. Pharmaceutical care practice: The clinician’s guide.  (2nd ed.), New York: McGraw-Hill 2004.

[6]
Secretary of Primary Health Care. Department of Health Promotion Pharmaceutical care collection in primary care: Application of the clinical method. Brasília: Ministry of Health 2020.

[7]
World Health Organization. Adherence to long-term therapies: Evidence for action. Geneva: WHO 2003.

[8]
Chevalier B, Watson BM, Barras MA, Cottrell WN. Developing preliminary steps in a pharmacist communication – patient outcome pathway. Can J Hosp Pharm  2019; 72(4): 271-81.
 [http://dx.doi.org/10.4212/cjhp.v72i4.2913] [PMID: 31452538]

[9]
Didier A, Dzemaili S, Perrenoud B, et al. Patients’ perspectives on interprofessional collaboration between health care professionals during hospitalization: A qualitative systematic review. JBI Evidence Synthesis  2020; 18(6): 1208-70.
 [http://dx.doi.org/10.11124/JBISRIR-D-19-00121] [PMID: 32813373]

[10]
Oliveira AM, Varallo FR, Rodrigues JPV, Pereira LRL. Protocol for the implementation of pharmaceutical care in geriatrics: Strategy for safety in health care. Rev Gaúcha Enferm  2022; 43: e20210236.
 [http://dx.doi.org/10.1590/1983-1447.2022.20210236.pt] [PMID: 36043645]

[11]
Pérez LM, Alonso RH, González MS, Marrero PSM, Molero GR. Evaluation of the quality of pharmaceutical interventions in emergencies based on scientific evidence. Farm Hosp  2014; 38(2): 123-9.
 [http://dx.doi.org/10.7399/FH.2014.38.2.981] [PMID: 24669897]

[12]
American Diabetes Association. 2. Classification and diagnosis of diabetes: Standards of medical care in diabetes-2021. Diabetes Care  2021; 44(S1): S15-33.
 [http://dx.doi.org/10.2337/dc21-S002] [PMID: 33298413]

[13]
World Health Organization. Medication safety in transitions of care. Geneva: WHO 2019.

[14]
González-Bueno J, Calvo-Cidoncha E, Sevilla-Sánchez D, Molist-Brunet N, Espaulella-Panicot J, Codina-Jané C. Person-centered prescription model to improve therapeutic adherence in patients with multimorbidity. Farm Hosp  2018; 42(3): 128-34.
 [PMID: 29730984]

[15]
de Oliveira AM, Varallo FR, Rodrigues JPV, Aguilar GJ, da Costa LNK, Leira PLR. Contribution of pharmaceutical care to person-centered health care and the safety of pharmacotherapy for hospitalized older individuals in Brazil: An investigative single-arm intervention trial. Curr Drug Saf  2023; 18(2): 253-63.
 [http://dx.doi.org/10.2174/1574886317666220614140433] [PMID: 35702788]

Rights & Permissions Print Cite

Journal Information

For Authors

For Editors

For Reviewers

Explore Articles

Open Access

Open Access Articles

For Visitors

DOI https://dx.doi.org/10.2174/1574885518666230606105152	Print ISSN 1574-8855
Publisher Name Bentham Science Publisher	Online ISSN 2212-3903

Current Drug Therapy

Empowerment Provided by Health Education and its Impact on Self-care: Report of a Pharmaceutical Intervention

Abstract Play Pause

Graphical Abstract

Abstract